<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02035475</url>
  </required_header>
  <id_info>
    <org_study_id>OH1-13-00471</org_study_id>
    <nct_id>NCT02035475</nct_id>
  </id_info>
  <brief_title>Prevention of Lymphoceles After Robotic PLND</brief_title>
  <acronym>PLND</acronym>
  <official_title>A Pilot Clinical Trial for the Prevention of Lymphoceles After Robotic Pelvic Lymph Node Dissections for Prostate Malignancies Using the da Vinci® EndoWrist® One™ Vessel Sealer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OhioHealth</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Intuitive Surgical</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>OhioHealth</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The EndoWrist One Vessel Sealer is a bipolar electrosurgical instrument for use with the da
      Vinci Si robotic surgical system. It is intended for bipolar coagulation and mechanical
      transection of vessels up to 7 mm in diameter and tissue bundles that fit within the jaws of
      the instrument. Their use in this study will be to perform tissue transection during PLND
      such that the intended use is within the FDA-approved domain for this instrument.
      Investigators intend to identify whether its use for PLND reduces lymphoceles given that the
      device is known to seal vessels up to 7 mm, which is much larger than lymphatic vessels
      encountered during PLND. Because the instrument is new and has been FDA approved for less
      than one year, there is no published literature regarding its use to date.

      Our hypothesis is that using the Vessel Sealer on a single side of the pelvis will reduce the
      incidence of screening detected lymphoceles on that side. Investigators propose a total
      sample size of 120 patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators propose a prospective, randomized, single-blinded study of patients diagnosed
      with pelvic cancer who are electing to undergo robotic surgery with PLND. The patients in our
      trial will be pelvic cancer patients at risk for lymphocele after PLND. Given the safe nature
      of the product and the patient's risk for lymphocele after PLND and subsequent potential
      morbidity, there is justification to give patients the option for inclusion in the study.
      Investigators intend to determine whether the rate of lymphocele formation after PLND at the
      time of robotic pelvic cancer surgery can be reduced by using the robotic Vessel Sealer
      unilaterally for the lymph node dissection. The side of the pelvis of each patient will be
      randomly selected by Excel's® random number function &quot;RAND()&quot; to receive the Vessel Sealer
      dissection. Investigators intend to use this device unilaterally so the contralateral side
      can serve as an internal control and eliminate patient specific confounding variables such as
      BMI, and surgeon specific factors such as degree and method of hemostasis utilized by each
      surgeon. In addition, Dr. Abaza will be the only surgeon performing these procedures,
      eliminating variation in technique between surgeons.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Lymphoceles</measure>
    <time_frame>4 months</time_frame>
    <description>Identify whether the use of the Vessel Sealer for PLND reduces the incidence of screening detected lymphoceles via CT scan of the pelvis by comparing the Vessel Sealer side of the pelvis with the control side of the pelvis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical Complications</measure>
    <time_frame>4 months</time_frame>
    <description>Evaluate perioperative and postoperative surgical outcomes at 4 months after surgery. Possible outcomes include &quot;no complications&quot; (0), &quot;minor complications&quot; (1), and &quot;major complications&quot; (2).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Lymphoceles</condition>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Intuitive Vessel Sealer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Maryland Bipolar Cautery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intuitive Vessel Sealer</intervention_name>
    <description>Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control.</description>
    <arm_group_label>Intuitive Vessel Sealer</arm_group_label>
    <arm_group_label>Maryland Bipolar Cautery</arm_group_label>
    <other_name>EndoWrist One Vessel Sealer</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 or older

          -  Candidate scheduled to undergo robotic prostatectomy surgery with PLND

        Exclusion Criteria:

          -  Age &lt; 18

          -  Unable to give informed consent

          -  Non-English speaking

          -  Not a candidate for robotic surgery for any reason
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronney Abaza, MD, FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>OhioHealth</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dublin Methodist Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2014</study_first_submitted>
  <study_first_submitted_qc>January 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2014</study_first_posted>
  <results_first_submitted>April 5, 2016</results_first_submitted>
  <results_first_submitted_qc>September 26, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 15, 2016</results_first_posted>
  <last_update_submitted>September 26, 2016</last_update_submitted>
  <last_update_submitted_qc>September 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>OhioHealth</investigator_affiliation>
    <investigator_full_name>Ronney Abaza</investigator_full_name>
    <investigator_title>Medical Director Robotic Surgery</investigator_title>
  </responsible_party>
  <keyword>Prevention</keyword>
  <keyword>Pelvic Lymph Node Dissection</keyword>
  <keyword>Lymphoceles</keyword>
  <keyword>Prostate Malignancies</keyword>
  <keyword>daVinci</keyword>
  <keyword>Vessel Sealer</keyword>
  <keyword>EndoWrist One</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphocele</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Prostatectomy patients were recruited from a single robotic urologists office, between 1/15/13 and 5/12/14. The final followup visit was completed on 12/18/14.</recruitment_details>
      <pre_assignment_details>Participants must be eligible for robotic procedures.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Intuitive Vessel Sealer</title>
          <description>Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control.
Intuitive Vessel Sealer: Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="120">120 subjects were consented for participation in the study.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="114">Six subjects did not complete the study due to withdrawal of consent.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Equipment Error</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intuitive Vessel Sealer</title>
          <description>Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control.
Intuitive Vessel Sealer: Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="114"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62.2" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Incidence of Lymphoceles</title>
        <description>Identify whether the use of the Vessel Sealer for PLND reduces the incidence of screening detected lymphoceles via CT scan of the pelvis by comparing the Vessel Sealer side of the pelvis with the control side of the pelvis.</description>
        <time_frame>4 months</time_frame>
        <population>Lymphoceles were identified by CT scan at 3 months post surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>EndoWrist 1 Vessel Sealer</title>
            <description>Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control.
The EndoWrist 1 Vessel Sealer was utilized on one side of the body, with each participant receiving both treatments, one each side.</description>
          </group>
          <group group_id="O2">
            <title>Fenestrated Maryland BiPolar Instrument</title>
            <description>The Fenestrated Maryland BiPolar Instrument was utilized on one side of the body, with each participant receiving both treatments, one each side.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Lymphoceles</title>
          <description>Identify whether the use of the Vessel Sealer for PLND reduces the incidence of screening detected lymphoceles via CT scan of the pelvis by comparing the Vessel Sealer side of the pelvis with the control side of the pelvis.</description>
          <population>Lymphoceles were identified by CT scan at 3 months post surgery.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="114"/>
                <count group_id="O2" value="114"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Lymphoceles</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Lymphoceles</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="104"/>
                    <measurement group_id="O2" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis is that there is no difference in the incidence of detected lymphoceles whether the EndoWrist 1 Vessel Sealer or the Fenestrated Maryland BiPolar Instrument were used.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.412</p_value>
            <method>McNemar</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Surgical Complications</title>
        <description>Evaluate perioperative and postoperative surgical outcomes at 4 months after surgery. Possible outcomes include “no complications” (0), “minor complications” (1), and “major complications” (2).</description>
        <time_frame>4 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Study Participants</title>
            <description>Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control.
Intuitive Vessel Sealer: Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control.</description>
          </group>
        </group_list>
        <measure>
          <title>Surgical Complications</title>
          <description>Evaluate perioperative and postoperative surgical outcomes at 4 months after surgery. Possible outcomes include “no complications” (0), “minor complications” (1), and “major complications” (2).</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="114"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Study Participants</title>
          <description>Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control.
Intuitive Vessel Sealer: Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="114"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Bilateral Pulmonary Embolisms</sub_title>
                <description>Shortness of breath. ER visit-CT angioplasty with thrombolysis and IVC filter placement with extended hospital (2 day) stay.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="114"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Rehospitalization</sub_title>
                <description>Rehospitalization due to fever and back pain.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="114"/>
              </event>
              <event>
                <sub_title>Prolonged existing hospitalization</sub_title>
                <description>Post-operative course complicated by syncope (likely vasovagal in context of pain), SOB, Ileus.</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="114"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="114"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Ronney Abaza</name_or_title>
      <organization>OhioHealth</organization>
      <phone>614-544-8104</phone>
      <email>ronney.abaza@ohiohealth.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

